Cooper Companies | COO - Sales Revenues

Stock Price
59.60
Daily Change
-0.78 -1.29%
Monthly
-14.10%
Yearly
-28.12%
Q2 Forecast
58.76

Cooper Companies reported $1.02B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Align Technology USD 1.04B 10M Mar/2026
AtriCure USD 141.2M 700K Mar/2026
Avanos Medical USD 182.2M 1.3M Mar/2026
Bausch Health Companies USD 2.5B 300M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dentsply International USD 880M 81M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Novartis USD 13.11B 750M Mar/2026
ResMed USD 1.4B 0 Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Steris USD 1.59B 90M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Utah Medical Products USD 9.04M 955K Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026